Home→Releases

Releases

CLASSYS Recruits Former Bain Partner to Drive Global Commercial Strategy

Releases

CLASSYS Recruits Former Bain Partner to Drive Global Commercial Strategy

To accelerate its push toward a $1 billion revenue target by 2030, medical aesthetics firm CLASSYS has appointed former Bain & Company partner Jung-hee Bae as its first Chief Commercial Officer. Bae will command a newly formed Go-to-Market Center, integrating sales and marketing divisions to scale presence across the Americas, China, and Europe.

Money Talk·Oct 12
Valmet to supply new board making line to Anhui Linping in China

Releases

Valmet to supply new board making line to Anhui Linping in China

Finnish technology provider Valmet has secured a contract to deliver a complete board making line, designated PM 9, to Anhui Linping Circular Development’s facility in Xiao County. The project aims to boost the Chinese manufacturer's output of lightweight fluting and liner grades, with start-up slated for 2028.

Money Talk·Oct 12
Ericsson Repurchases 7.9 Million Shares in October Buyback Push

Releases

Ericsson Repurchases 7.9 Million Shares in October Buyback Push

Between October 5 and October 9, 2026, Telefonaktiebolaget LM Ericsson repurchased 7,917,288 of its own Class B shares. The transactions, executed on Nasdaq Stockholm by Goldman Sachs Bank Europe SE, totaled approximately 746.4 million SEK as the company continues its ongoing 15 billion SEK buyback initiative.

Money Talk·Oct 12
Foresee Pharmaceuticals Gains Chinese Approval for CAMCEVI 42 mg

Releases

Foresee Pharmaceuticals Gains Chinese Approval for CAMCEVI 42 mg

China’s National Medical Products Administration has approved CAMCEVI 42 mg, a six-month subcutaneous treatment for advanced prostate cancer. Developed by Taipei-based Foresee Pharmaceuticals, the drug will be commercialized in the Chinese market by Changchun GeneScience Pharmaceutical, expanding the reach of the company's long-acting injectable therapy.

Money Talk·Oct 12
Ericsson Repurchases 7.9 Million Shares in October Buyback Push

Releases

Ericsson Repurchases 7.9 Million Shares in October Buyback Push

Between October 5 and October 9, 2026, Telefonaktiebolaget LM Ericsson acquired 7,917,288 of its own Class B shares. The transactions, executed on Nasdaq Stockholm by Goldman Sachs Bank Europe SE, totaled approximately 746.35 million SEK as the company continues its multi-billion SEK buyback program.

Shanghai positions itself as a global laboratory for AI in services

Releases

Shanghai positions itself as a global laboratory for AI in services

Forty-two multinational executives gathered in Shanghai on October 11 to chart the city's future as a hub for intelligent services. At the 38th International Business Leaders' Advisory Council, industry heavyweights argued that the city's industrial foundation makes it the ideal testing ground for integrating AI into the real economy.

Money Talk·Oct 12
Raytron OEM Debuts High-Speed Infrared Imaging for Industrial Automation

Releases

Raytron OEM Debuts High-Speed Infrared Imaging for Industrial Automation

At the VISION 2026 exhibition in Stuttgart, Raytron OEM demonstrated a suite of short-wave and long-wave infrared sensors designed to optimize industrial sorting and safety. The showcase centered on high-speed imaging hardware and thermal monitoring systems tailored for the rigorous demands of European manufacturing and automated quality control.

Money Talk·Oct 12
Why shopping intent beats hunger in the grocery aisle

Releases

Why shopping intent beats hunger in the grocery aisle

The conventional wisdom that shopping while hungry leads to impulse buys is largely a myth. New research from Breda University of Applied Sciences suggests that your motivation for entering the store—rather than your physical appetite—is the primary driver behind unplanned purchases in the grocery sector.

Money Talk·Oct 12
Anavex Life Sciences Faces Securities Class Action Over CEO Misconduct

Releases

Anavex Life Sciences Faces Securities Class Action Over CEO Misconduct

Investors who purchased Anavex Life Sciences shares between November 26, 2025, and August 28, 2026, are facing a legal deadline as a class action lawsuit moves forward. The litigation centers on claims that the company misled shareholders regarding regulatory hurdles linked to the actions of former CEO Christopher Missling.

Why shopping intent beats hunger in supermarket impulse buys

Releases

Why shopping intent beats hunger in supermarket impulse buys

The long-standing advice to avoid grocery shopping while hungry may be overstated. New research from Breda University of Applied Sciences suggests that a consumer's shopping intent—rather than their physical appetite—is the primary driver behind unplanned purchases, with browsing habits accounting for a nearly ninefold increase in impulse items.

Money Talk·Oct 12
Aardvark Therapeutics Faces Class Action Over ARD-101 Misrepresentations

Releases

Aardvark Therapeutics Faces Class Action Over ARD-101 Misrepresentations

Investors who purchased Aardvark Therapeutics shares between February 13, 2025, and May 14, 2026, face an October 13, 2026, deadline to join a class action lawsuit. The litigation targets alleged federal securities law violations stemming from the company's initial public offering and subsequent public statements regarding its drug pipeline.

Money Talk·Oct 12
Aardvark Therapeutics Faces Class Action Lawsuit Over Drug Safety Claims

Releases

Aardvark Therapeutics Faces Class Action Lawsuit Over Drug Safety Claims

Investors who purchased Aardvark Therapeutics shares between February 13, 2025, and May 14, 2026, face an October 13 deadline to join a securities fraud class action. The lawsuit, filed by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the safety and commercial potential of its ARD-101 drug candidate.

Money Talk·Oct 12
Phoenix Contact to Target Industrial AI and Cybersecurity at SPS 2026

Releases

Phoenix Contact to Target Industrial AI and Cybersecurity at SPS 2026

Nuremberg hosts the annual SPS trade show this November, where Phoenix Contact will debut its latest suite of automation tools. From November 24 to 26, the company plans to demonstrate how industrial AI and virtualized control systems can reshape manufacturing efficiency within the constraints of evolving cybersecurity regulations.

Money Talk·Oct 12
Investors Urged to Join Securities Fraud Class Action Against Webull

Releases

Investors Urged to Join Securities Fraud Class Action Against Webull

Shareholders who purchased Webull Corporation stock between April 26, 2025, and October 6, 2026, face a December 7, 2026, deadline to seek lead plaintiff status in a federal class action lawsuit. Schall, Brown & Schwartz LLP is representing investors alleging the firm misled the market regarding its operational reliance on China.

Money Talk·Oct 12
Webull Faces Class Action Over Alleged Misleading China Ties

Releases

Webull Faces Class Action Over Alleged Misleading China Ties

Investors who purchased Webull Corporation shares between April 26, 2025, and October 6, 2026, are being sought for a class action lawsuit. The litigation alleges the company misled the public regarding its operational independence from mainland China, potentially violating federal securities laws throughout the specified period.

Money Talk·Oct 12
Foxconn’s Kathy Yang Retains Spot on Fortune’s Most Powerful Women Asia

Releases

Foxconn’s Kathy Yang Retains Spot on Fortune’s Most Powerful Women Asia

For the second consecutive year, Kathy Yang of Hon Hai Technology Group has secured a place on Fortune’s Most Powerful Women Asia list. As the company’s General Manager of Global Campus Operations and head of its AI software and infrastructure divisions, Yang occupies a critical position at the nexus of industrial manufacturing and artificial intelligence.

Compass Faces Class Action Lawsuit Over Alleged Merger Misrepresentations

Releases

Compass Faces Class Action Lawsuit Over Alleged Merger Misrepresentations

Shareholders who acquired Compass, Inc. common stock during the January 2026 merger with Anywhere are being urged to join a class action lawsuit. Schall, Brown & Schwartz LLP claims the company misled investors regarding its regulatory compliance and the legal steps taken to finalize the transaction, leading to significant financial losses.

Money Talk·Oct 12
Compass Faces Class Action Over Alleged Merger Misrepresentations

Releases

Compass Faces Class Action Over Alleged Merger Misrepresentations

Investors who acquired Compass, Inc. stock during the January 2026 merger with Anywhere are facing a December 7, 2026 deadline to join a class action lawsuit. The litigation targets alleged federal securities law violations, claiming the company misled shareholders regarding regulatory compliance and the status of necessary permits during the acquisition process.

Netcapital Investors Face December Deadline in Securities Fraud Lawsuit

Releases

Netcapital Investors Face December Deadline in Securities Fraud Lawsuit

Investors who held Netcapital Inc. stock between December 15, 2021, and September 3, 2026, face a December 7 deadline to petition for lead plaintiff status. Schall, Brown & Schwartz LLP is spearheading the class action, alleging that the company misled shareholders through fabricated consulting revenue and forged agreements.

Global CEOs Scout Shanghai’s Fuxing Island for Innovation Potential

Releases

Global CEOs Scout Shanghai’s Fuxing Island for Innovation Potential

Fuxing Island transformed into a showcase for Shanghai’s industrial evolution on October 10 as 100 international business leaders gathered to inspect the city’s latest strides in artificial intelligence, robotics, and manufacturing. The event, held ahead of the 38th International Business Leaders' Advisory Council, underscored the city's shifting role in global technology.

Netcapital Faces Securities Class Action Over Alleged Fraudulent Accounting

Releases

Netcapital Faces Securities Class Action Over Alleged Fraudulent Accounting

Investors who held Netcapital Inc. stock between December 15, 2021, and September 3, 2026, face a critical window to join a class action lawsuit. The DJS Law Group is currently organizing plaintiffs to address allegations that the NASDAQ-listed company misled the market through forged consulting agreements and undisclosed related-party transactions.

Ensign Group Faces Securities Class Action Over Patient Care Allegations

Releases

Ensign Group Faces Securities Class Action Over Patient Care Allegations

Shareholders who held The Ensign Group stock between February 10, 2022, and June 18, 2026, face a December 7 deadline to petition for lead plaintiff status in a newly filed securities fraud lawsuit. The litigation claims the company misled investors regarding the quality of care provided at its nursing facilities.

Money Talk·Oct 12
Investors Urged to Join Securities Class Action Against Chemours

Releases

Investors Urged to Join Securities Class Action Against Chemours

Between February 20 and August 4, 2026, The Chemours Company allegedly misled shareholders regarding the actual market demand for its Opteon product line. Los Angeles-based law firm Schall, Brown & Schwartz LLP is now organizing a class action lawsuit, inviting investors who suffered financial losses to seek lead plaintiff status.

Investors Target The Ensign Group in Securities Class Action Lawsuit

Releases

Investors Target The Ensign Group in Securities Class Action Lawsuit

A federal class action lawsuit alleges that The Ensign Group misled shareholders by concealing systemic failures in patient care. The complaint, filed in the wake of the company’s performance between February 2022 and June 2026, claims management masked neglect within its facilities through deceptive self-reporting practices.

Chemours Faces Class Action Lawsuit Over Alleged Securities Violations

Releases

Chemours Faces Class Action Lawsuit Over Alleged Securities Violations

Investors who purchased The Chemours Company shares between February 20, 2026, and August 4, 2026, are being urged to contact the DJS Law Group regarding a pending class action lawsuit. The legal challenge alleges the chemical manufacturer misled the market by inflating demand for its Opteon product line.

Money Talk·Oct 12
Beyond Wall Street: Where U.S. Investors Are Embracing AI

Releases

Beyond Wall Street: Where U.S. Investors Are Embracing AI

California holds the top spot for AI-driven investment activity, yet the broader landscape defies traditional financial geography. Data from Investing.com reveals that while the home of Silicon Valley leads the nation, states like Ohio and Colorado are outperforming New York, signaling a shift in how retail investors access market intelligence.